Rajesh Bahekar

847 total citations
56 papers, 716 citations indexed

About

Rajesh Bahekar is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rajesh Bahekar has authored 56 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Organic Chemistry and 21 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rajesh Bahekar's work include Diabetes Treatment and Management (17 papers), Quinazolinone synthesis and applications (9 papers) and Pancreatic function and diabetes (9 papers). Rajesh Bahekar is often cited by papers focused on Diabetes Treatment and Management (17 papers), Quinazolinone synthesis and applications (9 papers) and Pancreatic function and diabetes (9 papers). Rajesh Bahekar collaborates with scholars based in India, United Kingdom and United States. Rajesh Bahekar's co-authors include Mukul R. Jain, Amit Joharapurkar, Dipam Patel, Samadhan Kshirsagar, Pankaj Patel, Vishal Patel, Nirav Dhanesha, Arun A. Gupta, Gaurang Shah and Shailesh R. Shah and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Pharmacology and European Journal of Cancer.

In The Last Decade

Rajesh Bahekar

53 papers receiving 700 citations

Peers

Rajesh Bahekar
Henrietta Dehmlow Switzerland
Stella Vincent United States
Gee‐Hong Kuo United States
Paige E. Mahaney United States
Harold B. Wood United States
Anthony L. Handlon United States
Alan D. Adams United States
Rajesh Bahekar
Citations per year, relative to Rajesh Bahekar Rajesh Bahekar (= 1×) peers Dipam Patel

Countries citing papers authored by Rajesh Bahekar

Since Specialization
Citations

This map shows the geographic impact of Rajesh Bahekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Bahekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Bahekar more than expected).

Fields of papers citing papers by Rajesh Bahekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Bahekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Bahekar. The network helps show where Rajesh Bahekar may publish in the future.

Co-authorship network of co-authors of Rajesh Bahekar

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Bahekar. A scholar is included among the top collaborators of Rajesh Bahekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Bahekar. Rajesh Bahekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giri, Suresh, Akshyaya Rath, Chitrang Trivedi, et al.. (2025). Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia. Vaccines. 13(9). 889–889.
2.
Jain, Mukul R., Rakesh B. Patel, Purvi Vyas, et al.. (2022). ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models. European Journal of Pharmacology. 924. 174961–174961. 5 indexed citations
3.
Bahekar, Rajesh, Shubhangi S. Soman, Dipam Patel, et al.. (2020). Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors. Bioorganic Chemistry. 99. 103851–103851. 4 indexed citations
4.
Bahekar, Rajesh, Shubhangi S. Soman, Dipam Patel, et al.. (2019). Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(11). 1313–1319. 2 indexed citations
5.
Joharapurkar, Amit, Samadhan Kshirsagar, Brijesh Sutariya, et al.. (2018). Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus. World Journal of Diabetes. 9(6). 80–91. 10 indexed citations
6.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2018). Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition. Chemico-Biological Interactions. 282. 13–21. 23 indexed citations
7.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2017). Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia. Biomedicine & Pharmacotherapy. 98. 364–371. 13 indexed citations
8.
Bahekar, Rajesh, Shailesh R. Shah, Dipam Patel, et al.. (2014). Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(8). 1918–1922. 17 indexed citations
9.
Patel, Vishal, Amit Joharapurkar, Nirav Dhanesha, et al.. (2013). Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice. Pharmacological Reports. 65(4). 927–936. 28 indexed citations
10.
Dhanesha, Nirav, Amit Joharapurkar, Gaurang Shah, et al.. (2013). Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice. European Journal of Pharmacology. 714(1-3). 188–192. 19 indexed citations
11.
Bahekar, Rajesh, Shailesh R. Shah, Dipam Patel, et al.. (2012). Long-acting peptidomimetics based DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3516–3521. 24 indexed citations
12.
Patel, Vishal, Amit Joharapurkar, Tejal Gandhi, et al.. (2012). Omeprazole improves the anti‐obesity and antidiabetic effects of exendin‐4 in db/db mice (奥美拉唑改善唾液素‐4 对db/db小鼠的减肥与降糖作用)*. Journal of Diabetes. 5(2). 163–171. 17 indexed citations
13.
Dhanesha, Nirav, Amit Joharapurkar, Gaurang Shah, et al.. (2012). Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect. Pharmacological Reports. 64(1). 140–149. 28 indexed citations
14.
Patel, Dipam, Mukul R. Jain, Shailesh R. Shah, et al.. (2011). Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1111–1117. 42 indexed citations
15.
Shah, Shailesh R., Suresh Pola, Priyanka Priyadarshini, et al.. (2010). Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification. Bioorganic & Medicinal Chemistry Letters. 21(2). 628–632. 7 indexed citations
16.
Shah, Shailesh R., Suresh Pola, Priyanka Priyadarshini, et al.. (2010). Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists. Bioorganic & Medicinal Chemistry. 19(2). 771–782. 13 indexed citations
17.
Bahekar, Rajesh, Mukul R. Jain, Arun A. Gupta, et al.. (2007). Synthesis and Antidiabetic Activity of 3,6,7‐Trisubstituted‐2‐(1H‐imidazol‐2‐ylsulfanyl)quinoxalines and Quinoxalin‐2‐yl isothioureas. Archiv der Pharmazie. 340(7). 359–366. 32 indexed citations
18.
Bahekar, Rajesh, et al.. (2002). Synthesis and Anticonvulsant Activity of 3-(6-Substituted-benzothiazol-2-yl)-6-phenyl-[1, 3]-xazinane-2-thiones. Archiv der Pharmazie. 335(8). 381–388. 27 indexed citations
19.
Bahekar, Rajesh, et al.. (2000). New Bronchodilators - 2 : Synthesis Of 6-Alkylbenzimidazo [1,2-C] Quinazolines. Indian Journal of Pharmaceutical Sciences. 62(1). 41. 5 indexed citations
20.
Mailavaram, Raghu Prasad, Rajesh Bahekar, & Raghuram Rao Akkinepally. (2000). ChemInform Abstract: Recent Perspectives in the Design of Antiasthmatic Agents. ChemInform. 31(41). 475–82. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026